Breaking News Instant updates and real-time market news.

DLB

Dolby

$61.57

-1.115 (-1.78%)

16:16
01/30/19
01/30
16:16
01/30/19
16:16

Dolby reports Q1 EPS 74c, consensus 53c

Reports Q1 revenue $302.4M, consensus $295.04M.

  • 30

    Jan

  • 25

    Feb

DLB Dolby
$61.57

-1.115 (-1.78%)

04/06/18
WBLR
04/06/18
NO CHANGE
WBLR
Outperform
Dolby relationship with Samsung may be strengthening, says William Blair
William Blair analyst Ralph Schackart points out that on February 25, the Samsung Galaxy S9/S9+ product line added Dolby Atmos to its smartphones. Dolby Atmos was launched in 2012 with a focus on the movie theater end-market, Schackart tells investors in a research note. The analyst views the development as potentially early evidence that the "historically rocky Samsung/Dolby relationship may be strengthening." He estimates the Atmos opportunity for Dolby in 2018 at roughly $8M in sales and about 6c in earnings per share. Schackart keeps an Outperform rating on Dolby.
04/25/18
WBLR
04/25/18
NO CHANGE
WBLR
Outperform
Dolby shares can reach mid-$80s over next 12 months, says William Blair
William Blair analyst Ralph Schackart attributes the post-earnings weakness in Dolby share to investors being disappointed by the "relatively weak" Q3 revenue guidance as well as foreign exchange-affected operating expense guidance. The analyst, however, sees optimism from management as a result of increasing full-year top-line guidance by $10M, despite a narrow beat on revenue this quarter. New products are still on pace to double in revenue in fiscal 2018, from a 2017 base of $60M, Schackart tells investors in a research note. He believes the shares over the next 12 months can reach the mid-$80s. The analyst maintains an Outperform rating on Dolby.
09/05/18
RFLF
09/05/18
INITIATION
Target $81
RFLF
Buy
Dolby initiated with a Buy at RF Lafferty
RF Lafferty initiated Dolby with a Buy and $81 price target.
09/07/18
TIGR
09/07/18
NO CHANGE
TIGR
Buy
Dolby licensing revenue producing steady positive trends, says Tigress Financial
Tigress Financial analyst Ivan Feinseth kept his Buy rating on Dolby, saying the company "continues to benefit from the integration of its audio and video enhancement technology in both consumer and commercial applications". The analyst adds that the company is leveraging its leading position in audio enhancement while also working to grow its key drivers in Dolby Voice, Dolby Vision, and Dolby Cinema continue. Feinseth further contends that Dolby's strong balance sheet and cash flow allow it to fund new product development and also maintain its return of cash to shareholders.

TODAY'S FREE FLY STORIES

RST

Rosetta Stone

$23.23

0.09 (0.39%)

08:06
06/24/19
06/24
08:06
06/24/19
08:06
Conference/Events
Rosetta Stone management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

PHR

Phreesia

$0.00

(0.00%)

08:05
06/24/19
06/24
08:05
06/24/19
08:05
Syndicate
Phreesia files registration statement for IPO »

Phreesia announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$35.22

0.2 (0.57%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Upgrade
NRG Energy rating change  »

NRG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$97.60

-0.97 (-0.98%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Conference/Events
Pinnacle West management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

BDSI

BioDelivery Sciences

$4.41

-0.05 (-1.12%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Hot Stocks
BioDelivery Sciences expands upon report from Pain Management Task Force »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAS

PhaseBio

$12.52

0.54 (4.51%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Conference/Events
PhaseBio management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

RBB

RBB Bancorp

$19.13

-0.45 (-2.30%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
RBB Bancorp announces 1M share repurchase program »

RBB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPL

Texas Pacific Land Trust

$773.00

-21 (-2.64%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
Texas Pacific Land Trust to explore conversion to C-corporation »

Texas Pacific Land Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.85

-3.94 (-3.32%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
Royal Caribbean, ITM Group partner to form new destination company »

Royal Caribbean and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTYH

GTY Technology Holdings

$7.64

-0.26 (-3.29%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
GTY Technology Holdings announces cooperative contract with Texas DIR »

GTY Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$74.34

0.94 (1.28%)

07:59
06/24/19
06/24
07:59
06/24/19
07:59
Hot Stocks
Alnylam presents new ONPATTRO results at 2019 PNS meeting »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

, UNH

UnitedHealth

$252.31

4.53 (1.83%)

07:57
06/24/19
06/24
07:57
06/24/19
07:57
Recommendations
HMS Holdings, UnitedHealth analyst commentary  »

HMS Holdings' recent…

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

UNH

UnitedHealth

$252.31

4.53 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Jul

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Caesars to adjourn Annual Meeting of shareholders »

Caesars Entertainment…

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

TTPH

Tetraphase

$0.63

-0.02 (-3.10%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Tetraphase presents new Xerava data at ASM »

Tetraphase announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

07:53
06/24/19
06/24
07:53
06/24/19
07:53
Initiation
Concert Pharmaceuticals initiated  »

SunTrust starts Concert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

WAB

Wabtec

$72.75

0.42 (0.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Downgrade
Wabtec rating change  »

Wabtec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHSP

SharpSpring

$12.84

-0.34 (-2.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Upgrade
SharpSpring rating change  »

SharpSpring upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$85.58

2.55 (3.07%)

07:50
06/24/19
06/24
07:50
06/24/19
07:50
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Sep

BARZ

5Barz

$0.00

(0.00%)

07:49
06/24/19
06/24
07:49
06/24/19
07:49
Hot Stocks
5Barz signs agreement with Kaynes Technology for Network Extender in India »

5BARz International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Earnings
LiveRamp raises FY20 revenue view to $363M-$377M from $358M-$372M »

Consensus $366.45M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBIX

Ebix

$47.71

0.48 (1.02%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Hot Stocks
Ebix expands A.D.A.M. Health Services business with client wins »

Ebix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$5.72

-0.07 (-1.21%)

07:46
06/24/19
06/24
07:46
06/24/19
07:46
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
LiveRamp to acquire Data Plus Math »

LiveRamp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Emerald Health receives cultivation license for cannabis operation in BC »

Emerald Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Icahn says 'pleased' with Caesars, Eldorado Resorts planned merger »

Carl Icahn said, …

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.